GNOTOBIO

Biomedical research

Grants

COST Action FA1401: European network on the factors affecting the gastro-intestinal microbial balance and the impact on the health status of pigs (PiGutNet), EU, 2014-2018. P. Trevisi - I.Splichal.

Commensal and probiotic bacteria in prevention of enteric infections in early postnatal period. Czech Science Foundation, 2013-2017, I. Splichal - V. Rada.

Benefits and risks of probiotics for immunocompromised newborns: a study in experimental models. Czech Science Foundation, 2013-2015, A. Splichalova.

Production of recombinant DNA-binding protein HMGB1 for diagnostis purposes. Ministry of industry and trade of the CR, 2012-2014, V. Vejvoda - I. Splichal.

Interplay of microbiota and gut function in the developing pig – Innovative avenues towards sustainable animal production. 7th FRP, EC, 2009-2013, H. Smidt - I. Splichal.

Antimicrobial peptides and Toll-like receptors in ontogeny and bacterial infections. Czech Science Foundation, 2009-2013, I. Splichal.

Induction of antimicrobial peptides in Salmonella-caused gastroenteritis in dependence on type lipopolysaccharide. MEYS, 2007-2011, I. Splichal.

Modulation of innate immune response by probiotic bacteria. Czech Science Foundation, 2007-2011, I. Splichal - V. Rada.

The role of EPEC virulence factors in inflammatory response of gnotobiotic pigs. Czech Science Foundation, 2005-2007, I. Splichal.

The role of cytokines in protection effect of live vaccinal strains of Salmonella. Czech Science Foundation, 2005-2007, I. Trebichavsky.

Research on natural immunity of fetal lungs in pig and laboratory animal models. MEYS, 2002-2004, I. Splichal.

Ontogeny of interleukin 18 production in pig and its role in bacterial infection. Czech Science Foundation, 2002-2004, I. Splichal.